Sunday, September 29, 2024

What is SARCOMA in the Abdomen?


What is SARCOMA in the Abdomen?

Abdominal Sarcomas are soft tissue sarcomas that can originate in adipose, muscular, nervous, fibrous tissues or in blood vessels. Those tumors that grow in the back of the abdominal cavity are called retroperitoneal sarcomas. Sarcomas in general are rare tumors.

Abdominal sarcoma refers to a type of cancer that originates in the soft tissues of the abdomen, which may include muscles, fat, blood vessels, nerves, and connective tissues. Sarcomas are rare cancers and can arise in various parts of the body, including the abdomen.

There are two main types of sarcomas:

1. Soft Tissue Sarcoma: This type originates in the soft tissues, such as fat, muscle, nerves, blood vessels, or connective tissues. In the abdomen, they may affect organs such as the stomach, intestines, liver, or kidneys.
2. Gastrointestinal Stromal Tumor (GIST): A specific type of soft tissue sarcoma that often occurs in the digestive tract, particularly the stomach or small intestine.

Common Types of Sarcoma in the Abdomen:

- Liposarcoma: Arises from fat cells.
- Leiomyosarcoma: Develops from smooth muscle tissue, often in the walls of the digestive tract.
- Fibrosarcoma: Originates from fibrous tissue.
- GIST: Affects the gastrointestinal tract.

Symptoms:

- Abdominal pain or discomfort
- A palpable mass in the abdomen
- Bloating or feeling of fullness
- Unexplained weight loss
- Nausea** or vomiting
- Changes in bowel habits

Diagnosis:

- Imaging tests (CT scan, MRI, or ultrasound)
- Biopsy to confirm the type of sarcoma
- Endoscopy (for gastrointestinal involvement)

Treatment:

- Surgery is often the primary treatment to remove the tumor.
- Radiation therapy or chemotherapy may be used to shrink the tumor before surgery or to address any remaining cancer cells after surgery.
- Targeted therapy may be used for specific sarcomas like GIST, especially if they have certain genetic mutations.

Abdominal sarcomas are rare but can be serious, and the treatment approach depends on the specific type, size, location, and whether the cancer has spread.

The Natural & Safe Solution is Ganotherapy

SICKNESS: CANCER

Cancer is a disease in which some of the body's cells grow uncontrollably and spread to other parts of the body. Cancer can start almost anywhere in the human body, which is made up of trillions of cells.

Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These abnormal cells can form tumors or invade nearby tissues and organs, interfering with normal bodily functions. 

Here are some Key Points about Cancer:

1. Cellular Abnormalities: Cancer begins when genetic mutations occur within normal cells, causing them to grow and multiply uncontrollably. These mutations may be inherited or acquired due to exposure to carcinogens (such as tobacco smoke, UV radiation, or certain chemicals) or other factors.

2. Tumor Formation: The uncontrolled growth of abnormal cells can lead to the formation of tumors. Tumors can be benign (non-cancerous), meaning they do not spread to other parts of the body, or malignant (cancerous), meaning they can invade nearby tissues and metastasize (spread) to other organs through the bloodstream or lymphatic system.

3. Types of Cancer: There are more than 100 different types of cancer, each classified based on the type of cells affected and their location in the body. Common types of cancer include breast cancer, lung cancer, prostate cancer, colorectal cancer, and skin cancer.

4. Symptoms: The signs and symptoms of cancer vary depending on the type and location of the cancer. Common symptoms may include persistent cough, changes in bowel or bladder habits, unexplained weight loss, unusual bleeding or discharge, and lumps or changes in the skin.

5. Diagnosis: Cancer is diagnosed through various methods, including physical examination, imaging tests (such as X-rays, CT scans, or MRIs), laboratory tests (such as blood tests or biopsies), and screening tests (such as mammograms or colonoscopies).

6. Treatment: Treatment options for cancer depend on factors such as the type and stage of cancer, as well as the patient's overall health and preferences. Treatment may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy, or a combination of these approaches.

7. Prevention: While not all cases of cancer are preventable, certain lifestyle changes can help reduce the risk of developing cancer. These include avoiding tobacco, maintaining a healthy weight, eating a balanced diet, limiting alcohol consumption, protecting the skin from sun exposure, and getting regular exercise.

BENEFITS THRU’ DXN PRODUCTS:

  • Inhibits Metastasis of cancer ( spread of cancer)
  • Improves recovery with Medical treatment
  • Reduces ‘side-effects’ of other therapies – Chemo/Radio
  • Inhibits further growth of ‘Tumour’
  • Reduces Pains of Cancer, Tumour and Surgery
  • Helps recovery from Protein Loss ( Hair loss particularly)
  • Improves general Energy; Improves memory functions
  • Extends ‘Life span’ ; Improves Q of living

PRODUCTS RECOMMENDED:






DISCLAIMER:
The dietary food supplements presented in this Page are designed to assist in the maintenance of general well-being through regular use. If you have a condition which requires medical diagnosis and treatment, it is important that you visit your healthcare professional.

The information presented on this page is for informational & educational purposes only, and is not intended as a medical advice or a substitute for a physician’s consultation and/or examination.

This page operated by an Independent DXN Distributor. DXN does not endorse any information on this site nor does DXN assume any civil and/or criminal liabilities arising out of this page.

Paano Ang Pag-inom o Paano Gamitin Ang DXN Products like RGGL at DXN Spirulina?


Bawat kalagayan ng kalusugan natin ay meron tamang pag gamit or pag inom ng ating DXN Products like DXN Food Supplements po. 

#1. HEALTHY PERSON:
meaning, walang health issue, kasama dito yong mga Bata, young woman, young man, or even old persons basta wala sila health issue.

Uminom ng RG&GL at SPIRULINA: 2 PAIRS to 6 pairs a day.
  • 2-6 RG
  • 2-6 GL
  • 2-6 SPIRULINA
#2. MAY HEALTH PROBLEM NA: nagagawa pa mga bagay-bagay, pero meron na Health Problem.

Uminom ng RG&GL at SPIRULINA: 6 PAIRS to 15 pairs a day.
  • 6-15 RG
  • 6-15 GL
  • 6-15 SPIRULINA
#3. MALALA NA ANG KARAMDAMAN: Pweding may Cancer na, meron na mga 'ITIS' ang sakit ng tao, limitado na ang galaw, pweding nakahiga nalang palagi, nakaupo nalang palagi, di na nagagawa mga dating ginagawa sa buhay, hindi na maka bili sa market, or nahihirapan na gumalaw ng mag isa.

DRINK MEGA DOSAGE! 

Uminom ng RG&GL at SPIRULINA: DRINK 30 pairs a day.
Paano Ang Pag-inom o Paano Gamitin Ang DXN Products like RG&GL at DXN Spirulina?

Monday, August 26, 2024

Wednesday, July 3, 2024

How To Join for FREE?


Makikita mo po ang mura or Discounted DXN Products Prices natin ay sa loob mismo po ng DXN Account mo.

Gawa ka lang po ng DXN Member Account mo online, libre po ang pag create, in less than 5 to 10 minutes gawa muna po nyan DXN Account mo, click mo lang po ang link sa ibaba po.

Here's the👍Simple & Easy STEPS To Create Your DXN ACCOUNT Online for FREE!

STEP 1️⃣ 
Click this link: https://bit.ly/libresumali

STEP 2️⃣ 
Click "SIGNUP FOR FREE" button.

STEP 3️⃣ 
Click "I have read and understand" (BLUE) button below to continue.

STEP 4️⃣ 
Country: Click [🔽-Select Country-🔽]
Kung saan po tayo naka tira kagaya tayo ay nasa Pinas, choose "PHILIPPINES" sa drop down menu.

Then, enter napo nyo ang inyong mga basic info sa online signup form ...

* COUNTRY:
* FULL NAME: (First name Middle Name Last Name)
* GENDER:
* BIRTH DATE: 
* NATIONALITY: [PHILIPPINO]
* MOBILE NO.:
* EMAIL:
* ADDRESS:
* STATE/PROVINCE:
* CITY/TOWN:
* POSTAL CODE:

BENEFICIARY INFORMATION (OPTIONAL)

Beneficiary Full Name:
Beneficiary Relationship:

STEP 5️⃣ 
REVIEW & CONTINUE

Once na ma filled up nyo napo, click "CONTINUE" button kapag lahat napo nalagyan nyo ng inyong personal info, at sa next page ay REVIEW your info, then CLICK nyo napo ang CHECK BOX as sumasangayon po kayo na tama mga data nyo na nilagay.

Then, hit the button sa baba uli to CONTINUE...

Then, finish the signup process till done and successfully register in DXN. Ang last page of your signing up is WELCOME LETTER, it means, your successfully register na po non.

IMPORTANT NOTE:
Kapag successful po, ang makikita nyo po sa last page ay WELCOME LETTER, meaning, tapos napo ang pag gawa nyo ng inyong DXN Account at it's time po na mag check na kayo ng iyong EMAIL INBOX dahil meron kana po non DXN ACTIVATION CODE para po ma-ACTIVATE nyo napo ang inyong DXN eWorld Member Account at sabay po kayo nyan gagawa ng iyong DXN LOGIN PASSWORD.





As a DXN Member, here is our DXN COMPENSATION & BENEFITS LIFETIME

DXN MEMBERS BENEFITS: 
(71% Compensation Payout)

01. Discount 15%-25% (Lifetime).

02. Retail Profit (any time)

03. Star Group Bonus (Lifetime) 37%.
  3.1. Personal Rebates
  3.2. Group Rebates

04. Cash Incentives: 
  4.1. PHP  12,500.00 | $ 300.00
  4.2. PHP 100,000.00 | $1,800.00

05. Development Bonus 15% (Lifetime).

06. Leadership Bonus 15% (Lifetime).

07. International Profit Sharing 2% (Lifetime).

08. Free Travel Seminar Incentive 2% (Lifetime).


10. Icing On the Cake (IOC) Program.




DXN's Marketing Plan

BEGINNING IS GOOD! 

As a qualified Star Agent and Star Ruby, you will enjoy:

- Star Group Bonus of 25% to 35%
- Development Bonus of 15%
- Cellphone Incentive
- Overseas Trip Cash Incentive
- Travel Seminar Incentive 1%
- Low Maintenance.

MIDDLE IS GOOD!

As a qualified Star Diamond to Gold Diamond, you will enjoy:

- Star Group Bonus of 37%
- Development Bonus of 15%
- Profit Sharing of 2%
- Travel Seminar Incentive of 2%
- Leadership Bonus of 5% to 8.3%.

ENDING IS GOOD!

As a qualified Crown Diamond to Crown Ambassador, you will enjoy:

- Star Group Bonus of 37%
- Development Bonus of 15%
- Profit Sharing of 2%
- Travel Seminar Incentive of 2%
- Leadership Bonus of 8.5% to 15%.


 

Congratulations to All 55 New DXN Distributors for the Month of JUNE 2024


Congratulations to All 55 New DXN Distributors from JUNE 1 - 30, 2024.

Worldwide Viral Team Builder's:

🇩🇿 Algeria = 1
🇵🇭 Philippines = 45
🇹🇿 Tanzania = 9

☑️ Gusto mo din ba mag earn ng POINTS at magkaroon MONTHLY REBATES?
☑️ Gusto mo ba maka DISCOUNT?
☑️ Gusto mo din ba makapag build ng sariling Network Organizations around the World?

Kung 'oo' ang sagot mo, congrats! dahil simply at madali lang ang pinaka unang gagawin mo, gagawa ka lang ng account mo, libre yong pag-gawa online!

SIGNUP FOR FREE Here!


DXN Signs Underwriting Agreement With Major Banks


DXN Holdings Bhd (DXN) has signed an underwriting agreement with Maybank Investment Bank Bhd, CIMB Investment Bank Bhd and RHB Investment Bank Bhd in conjunction with its proposed initial public offering (IPO) on the Main Market of Bursa Malaysia Securities Bhd.

DXN and its subsidiaries (DXN Group) are principally involved in the sales of health-oriented and wellness consumer products. It operates a vertically integrated supply chain with in-house research, cultivation and manufacturing functions across Malaysia, China, India, Indonesia and Mexico, and has over 300 stock keeping units of health-oriented and wellness consumer products that are manufactured in-house and distributed through its direct selling network or sales branches.

In conjunction with DXN’s IPO, Maybank Investment Bank Bhd, CIMB Investment Bank Bhd and RHB Investment Bank Bhd has agreed to underwrite the retail offering of 160,000,000 ordinary shares in DXN (Retail IPO Shares), representing approximately 3.2% of the enlarged issued ordinary shares in DXN. The Retail IPO Shares are to be offered in the following manner:

1/ 60,000,000 Retail IPO Shares are reserved for the directors and eligible employees of the DXN Group, and persons who have contributed to the success of the DXN Group; and
2/ 100,000,000 Retail IPO Shares are reserved for application by the Malaysian public via balloting.

DXN Non-Independent Executive Chairman and Founder Datuk Lim Siow Jin said, “The signing of the underwriting agreement marks a significant milestone for us ahead of our proposed listing on the Main Market of Bursa Malaysia Securities Bhd. Since we began operations, we have expanded our presence from being solely in the Malaysian market into international markets. 

We have a vast distribution footprint spanning across various global regions of Europe, Latin America, North America, Central Asia, South Asia, Southeast Asia, Middle East, Africa and Oceania and we are eyeing our next stage of growth as we aim to expand into new markets.”




DXN Unveils IPO Prospectus, Expects Market Cap Of RM3.8 Billion Post Listing


The Public Listing of DXN

DXN strives to ensure continuous growth and prosperity for its members by constantly developing. This spirit enabled DXN to be successfully relisted on Bursa Malaysia's main market on 19th May 2023, providing beneficial opportunities not only for DXN but also for all its members.

DXN IPO Prospectus Launch

The DXN IPO (Initial Public Offering) Prospectus Launch event was held on 28th April 2023 at DXN Cyberville. The event was attended by DXN's key management, directors, and staff, DXN Crown Ambassadors and DXN members from Malaysia and Overseas, officials and representatives from various banking and financial institutions, Bursa Malaysia officials, as well as members of the press.

DXN Unveils IPO Prospectus, Expects Market Cap Of RM3.8 Billion Post Listing

Main Market bound DXN Holdings Bhd which is involved in sales of health-oriented and wellness consumer products unveiled its initial public offering prospectus, which is set for 19 May 2023.

The IPO exercise involves an offering of up to 932,675,000 ordinary shares in DXN comprising an offer for sale of up to 772,675,000 existing Shares and a public issue of 160,000,000 new Shares. The maximum IPO price is RM0.76 per Share with the final IPO price to be determined via a book-building exercise.

The group will have an institutional offering of up to 772,675,000 Offer Shares, representing up to 15.5% of the enlarged issued Shares and up to 149,550,000 Offer Shares to Malaysian and foreign institutional and selected investors. While the retail offering is at 160,000,000 Issue Shares, representing 3.2% of the enlarged issued Shares.

The public issue is expected to raise approximately RM121.6 million of which the company has earmarked 65.8% or RM80 million of the public issue proceeds for the repayment of bank borrowings. Meanwhile, up to 14.4% or up to RM17.5 million has been budgeted for working capital requirements, mainly for the purchase of primary raw materials used to produce finished goods and primary packaging materials while the remaining public issue proceeds will be utilised to defray the fees and expenses relating to the IPO and listing.

Based on the enlarged issued Shares of 4,985,000,000 post-IPO and the retail price of RM0.76 per Share, DXN’s expected market capitalisation works out to be approximately RM3.8 billion. DXN also intends to declare a yearly dividend with a target payout ratio of between 30%-50% of its profit attributable to its owners on a consolidated basis.

DXN’s Non-Independent Executive Chairman and Founder, Datuk Lim Siow Jin said, “I am incredibly excited to launch our prospectus today. Over the years, we have invested into 2 research facilities, 6 cultivation facilities and 10 manufacturing facilities which have allowed us to control the supply chain and be innovative in expanding our product offerings to meet constantly changing customer needs. Looking ahead, we have another cultivation facility and 2 manufacturing facilities in the pipeline. Overall, DXN is poised for its next stage of growth through listing on the Main Market of Bursa Malaysia Securities Berhad. With over 3.6 million active members and revenue of over RM1.2 billion, we aim to continue our growth trajectory by expanding our presence in existing and new markets.”

Maybank Investment Bank Berhad is the Principal Adviser, Joint Global Coordinator, Joint Bookrunner, Joint Managing Underwriter and Joint Underwriter for the IPO. CIMB Investment Bank Berhad is the Joint Global Coordinator, Joint Bookrunner, Joint Managing Underwriter and Joint Underwriter for the IPO. CLSA Limited and CLSA Securities Malaysia Sdn Bhd are the Joint Global Coordinators and Joint Bookrunners for the IPO whereas RHB Investment Bank Berhad is the Joint Bookrunner and Joint Underwriter for the IPO.